Perhaps an interesting line of investigation is mitochondrial-targeted protectors such as melatonin for early stages in PD [55] or growth hormone (GH) and insulin growth-factor 1 (IGF-1) supplementation in T2DM [56], but further studies are needed in this respect. Here, IGF1 is linked to Parkinson disease.